In February, South Africa delayed vaccination with AstraZeneca's drug. As scientists reported,
it was much less effective against the South African strain of COVID-19prevailing in the country Oxford University and
AstraZeneca have begun clinical trials of a vaccine developed against the South African variant of the
coronavirus, Le Figaro reported. The trials will involve about 2,25......